A Republican strategy for addressing drug shortages as part of user fee legislation appears to still include regulatory streamlining and reimbursement changes even as legislation to require more notification builds steam.
Rep. John Shimkus, R-Ill. suggested regulations may need to be changed to bring additional manufacturers online quicker in shortage situations
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?